Syndecan-1

Syndecan-1 분자 정보

영어 이름Syndecan-1시판 약물 수0
임상 약물 수2표적 별명Syndecan Proteoglycan 1,CD138 Antigen,SYND1,SDC,Heparan Sulfate Proteoglycan Fibroblast Growth Factor Receptor,Syndecan,CD138,Syndecan-1,SDC1,Syndecan 1
최고 연구 개발 단계Phase 1 Clinical
영어 이름Syndecan-1
표적 별명Syndecan Proteoglycan 1,CD138 Antigen,SYND1,SDC,Heparan Sulfate Proteoglycan Fibroblast Growth Factor Receptor,Syndecan,CD138,Syndecan-1,SDC1,Syndecan 1
시판 약물 수0
임상 약물 수2
최고 연구 개발 단계Phase 1 Clinical

Syndecan-1 제품 목록

  • 속성

    Protein (5)

  • 제품 라이브러리

    온라인 (5)

  • Human (5)

  • 태그

    His Tag & Avi Tag (1)Fc Tag & Avi Tag (1)Fc Tag (1)His Tag (2)

  • 마커

    Biotin-labeled (2)Unconjugated (2)FITC Labeled (1)

Syndecan-1분자 배경

Syndecan-1 (SYND1 or SDC1) is also known as CD antigen CD138, is a transmembrane (type I) heparan sulfate proteoglycan and is a member of the syndecan proteoglycan family. The syndecans mediate cell binding, cell signaling, and cytoskeletal organization and syndecan receptors are required for internalization of the HIV-1 tat protein. The syndecan-1 / SDC1 protein functions as an integral membrane protein and participates in cell proliferation, cell migration and cell-matrix interactions via its receptor for extracellular matrix proteins. It is a useful marker for plasma cells, but only if the cells tested are already known to be derived from blood.

Syndecan-1분자 별명

SDC1,Syndecan-1,CD138,SYND1,SDC

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
ATLCAR.CD138 (UNC Lineberger Comprehensive Cancer Center)Phase 1 ClinicalUnc Lineberger Comprehensive Cancer CenterImmune System Diseases; Multiple Myeloma
상세
QXL-138AMQXL-138AMPhase 1 ClinicalNammi Therapeutics IncBreast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Gastrointestinal Neoplasms; Lung Neoplasms; Multiple Myeloma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Solid tumours
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호